CAS: 1467093-03-3
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
Adavivint REF: IN-DA01EO6VCAS: 1467093-03-3 | 97% | To inquire | Tue 07 Jan 25 | |
Adavivint REF: TM-T5636CAS: 1467093-03-3 | 98.27% - ≥98% | 47.00 €~510.00 € | Tue 14 Jan 25 | |
Adavivint REF: TR-A208260CAS: 1467093-03-3 | - - - | 15,266.00 € | Tue 18 Feb 25 | |
Adavivint REF: 3D-SIC09303CAS: 1467093-03-3 | Min. 95% | To inquire | Tue 18 Feb 25 |
Ref: IN-DA01EO6V
1mg | 71.00 € | ||
5mg | 169.00 € | ||
10mg | 160.00 € | ||
25mg | 235.00 € | ||
50mg | 326.00 € |
Estimated delivery in United States, on Tuesday 7 Jan 2025
Adavivint
CAS:1467093-03-3
Adavivint (Adavivint (SM04690)) (SM04690) is a Wnt pathway inhibitor.
Formula:
C29H24FN7O
Purity:
98.27% - ≥98%
Color and Shape:
Solid
Molecular weight:
505.55
Ref: TM-T5636
1mg | 47.00 € | ||
5mg | 91.00 € | ||
10mg | 122.00 € | ||
25mg | 193.00 € | ||
50mg | 343.00 € | ||
100mg | 510.00 € | ||
1mL*10mM (DMSO) | 96.00 € |
Estimated delivery in United States, on Tuesday 14 Jan 2025
Adavivint
Controlled ProductCAS:1467093-03-3
Formula:
C29H24FN7O
Color and Shape:
Neat
Molecular weight:
505.546
Ref: TR-A208260
50mg | 15,266.00 € |
Estimated delivery in United States, on Tuesday 18 Feb 2025
Adavivint
CAS:1467093-03-3
Adavivint is a genetically engineered human TNF-α protein. It is a recombinant human tumor necrosis …
Formula:
C29H24FN7O
Purity:
Min. 95%
Molecular weight:
505.55 g/mol
Ref: 3D-SIC09303
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Tuesday 18 Feb 2025